Instruction for use: SelegilineI want this, give me price
Dosage form: tablets
Active substance: Selegiline*
The nosological classification (ICD-10)
G20 Parkinson's disease: A trembling paralysis; Idiopathic Parkinsonism; Parkinson's disease; Symptomatic Parkinsonism
G21 Secondary Parkinsonism: Medicinal Parkinsonism; Parkinsonism; Parkinsonism symptomatic; Disorders of extrapyramidal system; Parkinson's Syndrome
Composition and release form
1 tablet contains selegiline hydrochloride 5 mg; In blistere 10 pcs., In a cardboard bundle 5 blisters.
Mode of action - antiparkinsonian.
Inhibits MAO type B and increases the content of dopamine (and other tyramine-like substances) in the synapses of various parts of the brain, incl. Nuclei of the extrapyramidal system.
Indication of the drug Selegiline
Parkinson's disease, Parkinsonism.
Application in pregnancy and breastfeeding
When appointing pregnant and lactating mothers, risk and therapeutic benefit should be compared.
Decrease AD, nausea, confusion, psychosis.
Strengthens and lengthens the effect of levodopa.
Dosing and Administration
Inside, starting with 1 tab. In the morning (together with breakfast); With insufficient effect, the dose is increased to 2 tablets. per day.
Symptoms are agitation and involuntary movements that disappear when the dose is lowered.
Caution is prescribed for cardiovascular, endocrine diseases, gastrointestinal disorders, impaired renal function, glaucoma.
Storage conditions of the drug Selegiline
In a dry place, at a temperature below 25 ° C.
Keep out of the reach of children.
Shelf life of the drug Selegiline
Do not use after the expiry date printed on the package.